GOG-263: Randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer treated with initial radical hysterectomy and pelvic lymphadenectomy,
Role: Investigator,
Southwest Oncology Group,
(09/2024 - 09/2025)
Status: Approved
Southwest Oncology Group (SWOG) S1609: DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in rare tumors,
Role: Investigator,
Southwest Oncology Group,
(12/2024 - 12/2025)
Status: Approved
SWOG / NRG-GY009: A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer,
Role: Investigator,
Southwest Oncology Group,
(12/2019)
Status: Completed
SWOG 9318. Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix. Phase II,
Role: Investigator,
Southwest Oncology Group,
(01/2005 - 01/2006)
Status: Completed
A Double-blind, Multicenter, Parallel Study Comparing the Efficacy and Safety of Oral Granisetron Hydrochloride 2 mg with Intravenous Ondansetron Hydrochloride 32 mg Given Once Prior to Chemotherapy in the Prevention of Nausea and Vomiting Induced by Cisplatin-based Chemotherapy,
Role: PI,
Smithkline Beecham,
(01/1996 - 01/1997)
Status: Completed
Internal
Investigator initiated: Conventional prophylactic regimen of oral dexamethasone versus short-course intravenous dexamethasone in preventing paclitaxel-related hypersensitivity reactions in breast and gynecologic-oncology patients: A prospective, randomized, open-label study,
Role: Investigator,
LLU Dept. of Gynecology & Obstetrics,
(02/2024 - 01/2025)
Status: Completed
Investigator initiated: Retrospective analysis to determine the incidence of Occult Cervical cancer in patients with Adenocarcinoma in situ at LLU,
Role: Investigator,
LLU Dept. of Gynecology & Obstetrics,
(02/2019)
Status: Approved
Sexual and marital dysfunction in women with gynecologic cancer,
Role: Investigator,
LLU Dept. of Gynecology & Obstetrics,
(06/2015 - 06/2016)
Status: Completed
Compassionate use of everolimus: Individual patient program (IPP) for treatment of recurrent progressive clear cell endocervical cancer with everolimus,
Role: Investigator,
LLU Dept. of Gynecology & Obstetrics,
Status: Completed